Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bertilsson

Showing results (241-250 of 263) with videos related to

Pageof 27
Sort By:
Antimicrobial Agents and Chemotherapy|November 19, 2008
Voriconazole increases while itraconazole decreases plasma meloxicam concentrationsV V Hynninen, K T Olkkola, L Bertilsson, et al.
EXS|January 1, 1994
Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicityM Ingelman-Sundberg, I Johansson, I Persson, et al.
Lancet (London, England)|January 2, 1993
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquineL Bertilsson, M L Dahl, F Sjöqvist, et al.
Clinical Pharmacology and Therapeutics|November 1, 1979
Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depressionL Träskman, M Asberg, L Bertilsson, et al.
British Journal of Clinical Pharmacology|September 19, 2001
Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patientsH K Roh, J Y Chung, D Y Oh, et al.
Pharmacogenetics|December 11, 1999
Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquineM L Bernal, B Sinues, I Johansson, et al.
Pharmacogenetics|April 1, 1993
Quinidine inhibition of debrisoquine S(+)-4- and 7-hydroxylations in Chinese of different CYP2D6 genotypesL Bertilsson, C O Meese, Q Y Yue, et al.
British Journal of Clinical Pharmacology|December 1, 1996
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humansY Böttiger, P Dostert, M S Benedetti, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeineI Johansson, Q Y Yue, M L Dahl, et al.
The Pharmacogenomics Journal|October 24, 2012
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patientsA Habtewold, W Amogne, E Makonnen, et al.
Pageof 27

Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Antimicrobial Agents and Chemotherapy|November 19, 2008
Voriconazole increases while itraconazole decreases plasma meloxicam concentrationsV V Hynninen, K T Olkkola, L Bertilsson, et al.
EXS|January 1, 1994
Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicityM Ingelman-Sundberg, I Johansson, I Persson, et al.
Lancet (London, England)|January 2, 1993
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquineL Bertilsson, M L Dahl, F Sjöqvist, et al.
Clinical Pharmacology and Therapeutics|November 1, 1979
Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depressionL Träskman, M Asberg, L Bertilsson, et al.
British Journal of Clinical Pharmacology|September 19, 2001
Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patientsH K Roh, J Y Chung, D Y Oh, et al.
Pharmacogenetics|December 11, 1999
Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquineM L Bernal, B Sinues, I Johansson, et al.
Pharmacogenetics|April 1, 1993
Quinidine inhibition of debrisoquine S(+)-4- and 7-hydroxylations in Chinese of different CYP2D6 genotypesL Bertilsson, C O Meese, Q Y Yue, et al.
British Journal of Clinical Pharmacology|December 1, 1996
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humansY Böttiger, P Dostert, M S Benedetti, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeineI Johansson, Q Y Yue, M L Dahl, et al.
The Pharmacogenomics Journal|October 24, 2012
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patientsA Habtewold, W Amogne, E Makonnen, et al.
Pageof 27